Alliancebernstein L.P. Allovir, Inc. Transaction History

Alliancebernstein L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.68 - $2.39 $4,243 - $14,913	-6,240 Reduced 8.83%	64,430 $43,000
Q3 2023 Nov 14, 2023	BUY	$2.15 - $3.64 $22,274 - $37,710	10,360 Added 17.18%	70,670 $151,000
Q2 2023 Aug 15, 2023	BUY	$3.17 - $5.82 $50,117 - $92,014	15,810 Added 35.53%	60,310 $205,000
Q1 2023 May 15, 2023	BUY	$3.94 - $7.05 $21,670 - $38,775	5,500 Added 14.1%	44,500 $175,000
Q4 2022 Feb 14, 2023	BUY	$4.7 - $9.98 $49,350 - $104,790	10,500 Added 36.84%	39,000 $200,000
Q3 2022 Nov 15, 2022	BUY	$4.13 - $8.79 $7,021 - $14,942	1,700 Added 6.34%	28,500 $225,000
Q2 2022 Aug 15, 2022	BUY	$3.26 - $7.06 $14,669 - $31,770	4,500 Added 20.18%	26,800 $105,000
Q4 2021 Feb 14, 2022	SELL	$12.94 - $25.99 $441,771 - $887,298	-34,140 Reduced 60.49%	22,300 $289,000
Q3 2021 Nov 10, 2021	SELL	$16.97 - $25.06 $21.7 Million - $32 Million	-1,277,689 Reduced 95.77%	56,440 $1.41 Million
Q2 2021 Jul 30, 2021	BUY	$19.44 - $25.06 $4.56 Million - $5.87 Million	234,329 Added 21.31%	1,334,129 $26.3 Million
Q1 2021 May 06, 2021	BUY	$20.81 - $45.5 $1.63 Million - $3.56 Million	78,189 Added 7.65%	1,099,800 $25.7 Million
Q4 2020 Feb 08, 2021	BUY	$23.94 - $46.81 $1.51 Million - $2.94 Million	62,868 Added 6.56%	1,021,611 $39.3 Million
Q3 2020 Nov 12, 2020	BUY	$21.05 - $42.7 $20.2 Million - $40.9 Million	958,743 New	958,743 $26.4 Million

44.4M

14.9K

200

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $933M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.